ATE530516T1 - Exo- und diastereoselektive synthese von himbacin-analoga - Google Patents

Exo- und diastereoselektive synthese von himbacin-analoga

Info

Publication number
ATE530516T1
ATE530516T1 AT10001844T AT10001844T ATE530516T1 AT E530516 T1 ATE530516 T1 AT E530516T1 AT 10001844 T AT10001844 T AT 10001844T AT 10001844 T AT10001844 T AT 10001844T AT E530516 T1 ATE530516 T1 AT E530516T1
Authority
AT
Austria
Prior art keywords
exo
diastereoselective synthesis
himbacin
analogs
himbacin analogs
Prior art date
Application number
AT10001844T
Other languages
English (en)
Inventor
George G Wu
Anantha Sudhakar
Tao Wang
Ji Xie
Frank Xing Chen
Marc Poirier
Mingsheng Huang
Vijay Sabesen
Daw-Long Kwok
Jian Cui
Xiaojing Yang
Tiruvettipuram K Thiruvengadam
Jing Liao
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ATE530516T1 publication Critical patent/ATE530516T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/10—Preparation of nitro compounds by substitution of functional groups by nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/12—Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/44—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
    • C07C205/55—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups or carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/07—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton
    • C07C309/08—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing oxygen atoms bound to the carbon skeleton containing hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/606—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom having only or additionally carbon-to-carbon triple bonds as unsaturation in the carboxylic acid moiety
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92—Naphthofurans; Hydrogenated naphthofurans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576—Six-membered rings
    • C07F9/58—Pyridine rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
AT10001844T 2005-01-14 2006-01-12 Exo- und diastereoselektive synthese von himbacin-analoga ATE530516T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US64446405P 2005-01-14 2005-01-14

Publications (1)

Publication Number Publication Date
ATE530516T1 true ATE530516T1 (de) 2011-11-15

Family

ID=36168544

Family Applications (2)

Application Number Title Priority Date Filing Date
AT10001844T ATE530516T1 (de) 2005-01-14 2006-01-12 Exo- und diastereoselektive synthese von himbacin-analoga
AT06718069T ATE458726T1 (de) 2005-01-14 2006-01-12 Exo- und diastereoselektive synthese von himbacin-analoga

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT06718069T ATE458726T1 (de) 2005-01-14 2006-01-12 Exo- und diastereoselektive synthese von himbacin-analoga

Country Status (21)

Country Link
US (4) US7605275B2 (de)
EP (4) EP1848705B1 (de)
JP (3) JP4681616B2 (de)
CN (2) CN102757423B (de)
AR (1) AR056919A1 (de)
AT (2) ATE530516T1 (de)
CA (2) CA2594871C (de)
CY (2) CY1109896T1 (de)
DE (1) DE602006012450D1 (de)
DK (2) DK2206697T3 (de)
ES (3) ES2339696T3 (de)
HR (2) HRP20100218T1 (de)
ME (1) ME01967B (de)
MX (1) MX2007008665A (de)
PL (2) PL2206697T3 (de)
PT (2) PT1848705E (de)
RS (2) RS51315B (de)
SG (2) SG158888A1 (de)
SI (2) SI2206697T1 (de)
WO (1) WO2006076415A2 (de)
ZA (1) ZA200706711B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7488742B2 (en) * 2000-06-15 2009-02-10 Schering Corporation Thrombin receptor antagonists
JP4681617B2 (ja) * 2005-01-14 2011-05-11 シェーリング コーポレイション ヒンバシンアナログの合成
JP4775971B2 (ja) * 2005-01-14 2011-09-21 シェーリング コーポレイション ヒンバシンアナログのエキソ−選択的合成
ATE530516T1 (de) 2005-01-14 2011-11-15 Schering Corp Exo- und diastereoselektive synthese von himbacin-analoga
EP1971336A2 (de) * 2005-12-22 2008-09-24 Shering Corporation Thrombin-rezeptor-antagonisten zur prophylaxe vor komplikationen einer kardiopulmonalen operation
AR061727A1 (es) * 2006-06-30 2008-09-17 Schering Corp Sintesis de dietil [[ 5- ( 3-fluorofenil) -piridin -2il] metil] fosfonato
US7553987B2 (en) * 2006-06-30 2009-06-30 Schering Corporation Synthesis of 3-(5-nitrocyclohex-1-enyl) acrylic acid and esters thereof
MX2009006477A (es) * 2006-12-15 2009-06-26 Schering Corp Purificacion de bisulfito de una alfa-ceto amida.
ES2667945T3 (es) 2007-10-08 2018-05-16 Aurinia Pharmaceuticals Inc. Composiciones oftálmicas que comprenden inhibidores de calcineurina o Inhibidores de mTOR
MX2010004453A (es) * 2007-10-24 2010-07-28 Schering Corp Procedimiento sintetico de alta pureza para la preparacion de intermediarios de ester de acido dodecahidro-nafto-furanil-carbami co.
US9120935B2 (en) * 2011-06-21 2015-09-01 Bluestar Silicones France Sas Hydrosilylation reaction inhibitors, and use thereof for preparing stable curable silicone compositions
CN105330689B (zh) * 2014-08-08 2018-08-17 博瑞生物医药（苏州）股份有限公司 制备Himbacine类似物中间体的制备方法
CN105985303B (zh) * 2015-02-13 2020-08-14 上海彩迩文生化科技有限公司 抗凝血剂的制备方法、中间体及其制备方法
CN105348241B (zh) * 2015-12-11 2017-09-05 南京华威医药科技开发有限公司 一种硫酸沃拉帕沙中间体的合成方法
US11247940B2 (en) 2016-10-26 2022-02-15 The Regents Of The University Of California Efficient integration of manufacturing of upcycled concrete product into power plants
CN106749138B (zh) * 2016-12-07 2019-08-16 扬子江药业集团四川海蓉药业有限公司 一种硫酸沃拉帕沙中间体醛的制备方法
CN106866450B (zh) * 2017-01-13 2019-01-11 阜阳欣奕华材料科技有限公司 硫酸沃拉帕沙中间体的制备方法
CN108658910B (zh) * 2017-03-29 2020-11-03 北京新领先医药科技发展有限公司 一种沃拉帕沙中间体1-α的制备方法
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis
US11230473B2 (en) 2017-06-30 2022-01-25 The Regents Of The University Of California CO2 mineralization in produced and industrial effluent water by pH-swing carbonation
EP3668820A4 (de) 2017-08-14 2021-05-05 The Regents of the University of California, A California Corporation Verminderung der alkali-silica-reaktion in beton unter verwendung von leicht löslichen chemischen additiven
WO2019057946A1 (en) 2017-09-25 2019-03-28 F. Hoffmann-La Roche Ag MULTI-CYCLIC AROMATIC COMPOUNDS AS D-FACTOR INHIBITORS
US11384029B2 (en) 2019-03-18 2022-07-12 The Regents Of The University Of California Formulations and processing of cementitious components to meet target strength and CO2 uptake criteria
WO2023069370A1 (en) 2021-10-18 2023-04-27 The Regents Of The University Of California Integration of direct air capture system into co2 mineralizaton process of concretes and aggregates
WO2023158879A1 (en) 2022-02-21 2023-08-24 Carbonbuilt Methods and systems for biomass-derived co 2 sequestration in concrete and aggregates
EP4508020A1 (de) 2022-04-12 2025-02-19 CarbonBuilt Verfahren zur herstellung von hydraulisch-karbonisierenden bindemittelsystemen durch mechanochemische aktivierung von mineralien
US12203184B2 (en) 2022-07-18 2025-01-21 The Regents Of The University Of California Multi-chambered electrochemical cell for carbon dioxide removal
TW202432895A (zh) 2023-01-31 2024-08-16 美國加利福尼亞大學董事會 氧選擇性陽極

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100393492B1 (ko) * 1997-11-25 2003-08-02 쉐링 코포레이션 트롬빈 수용체 길항제
US6063847A (en) * 1997-11-25 2000-05-16 Schering Corporation Thrombin receptor antagonists
UA81595C2 (en) * 1998-05-05 2008-01-25 Эли Лилли Энд Компани Process for the purification of carboxaldehyde
US7235567B2 (en) * 2000-06-15 2007-06-26 Schering Corporation Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
US20040192753A1 (en) 2000-06-15 2004-09-30 Samuel Chackalamannil Methods of use of thrombin receptor antagonists
US7488742B2 (en) * 2000-06-15 2009-02-10 Schering Corporation Thrombin receptor antagonists
US7304078B2 (en) * 2002-04-16 2007-12-04 Schering Corporation Thrombin receptor antagonists
ES2291323T3 (es) * 2000-06-15 2008-03-01 Schering Corporation Antagonistas de receptores de trombina.
US8124625B2 (en) * 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
BR0213967A (pt) * 2001-10-18 2005-08-30 Schering Corp Análogos de himbacina como antagonistas do receptor de trombina
MXPA06013903A (es) * 2004-05-28 2007-01-26 Schering Corp Analogos restringidos de himbacina como antagonistas del receptor de trombina.
JP4681617B2 (ja) * 2005-01-14 2011-05-11 シェーリング コーポレイション ヒンバシンアナログの合成
JP4775971B2 (ja) * 2005-01-14 2011-09-21 シェーリング コーポレイション ヒンバシンアナログのエキソ−選択的合成
ATE530516T1 (de) 2005-01-14 2011-11-15 Schering Corp Exo- und diastereoselektive synthese von himbacin-analoga
US7541471B2 (en) * 2005-01-14 2009-06-02 Schering Corporation Synthesis of himbacine analogs

Also Published As

Publication number Publication date
JP2011098967A (ja) 2011-05-19
US7605275B2 (en) 2009-10-20
ZA200706711B (en) 2014-01-29
US20110251392A1 (en) 2011-10-13
JP2013177407A (ja) 2013-09-09
JP4681616B2 (ja) 2011-05-11
JP5911447B2 (ja) 2016-04-27
ME01967B (me) 2012-08-31
WO2006076415A2 (en) 2006-07-20
CN101193880A (zh) 2008-06-04
EP2196468B1 (de) 2013-04-10
MX2007008665A (es) 2008-03-04
CA2875768A1 (en) 2006-07-20
DK1848705T3 (da) 2010-06-14
SI1848705T1 (sl) 2010-06-30
EP1848705A2 (de) 2007-10-31
JP5388231B2 (ja) 2014-01-15
EP2196468A1 (de) 2010-06-16
EP2206697A1 (de) 2010-07-14
PT1848705E (pt) 2010-05-10
CN102757423B (zh) 2016-04-20
ATE458726T1 (de) 2010-03-15
EP2206697B1 (de) 2011-10-26
ES2412981T3 (es) 2013-07-15
EP1848705B1 (de) 2010-02-24
ES2339696T3 (es) 2010-05-24
CN102757423A (zh) 2012-10-31
US20060247450A1 (en) 2006-11-02
SI2206697T1 (sl) 2012-02-29
ES2374379T3 (es) 2012-02-16
EP2196454B1 (de) 2014-08-27
US8258319B2 (en) 2012-09-04
WO2006076415A3 (en) 2006-11-16
JP2008526972A (ja) 2008-07-24
CA2594871C (en) 2015-04-07
PT2206697E (pt) 2012-01-10
SG158888A1 (en) 2010-02-26
CY1109896T1 (el) 2014-09-10
EP2196454A2 (de) 2010-06-16
DE602006012450D1 (de) 2010-04-08
CN101193880B (zh) 2012-08-22
US20120296093A1 (en) 2012-11-22
CA2875768C (en) 2018-03-06
PL1848705T3 (pl) 2010-07-30
HK1108893A1 (en) 2008-05-23
RS51315B (sr) 2010-12-31
EP2196454A3 (de) 2010-09-22
DK2206697T3 (da) 2012-02-13
HRP20100218T1 (hr) 2010-05-31
HRP20110963T1 (hr) 2012-01-31
CY1112371T1 (el) 2015-12-09
AR056919A1 (es) 2007-11-07
SG192505A1 (en) 2013-08-30
US7989653B2 (en) 2011-08-02
US20090281321A1 (en) 2009-11-12
RS52117B (sr) 2012-08-31
CA2594871A1 (en) 2006-07-20
US8618314B2 (en) 2013-12-31
PL2206697T3 (pl) 2012-03-30

Similar Documents

Publication Publication Date Title
ATE530516T1 (de) Exo- und diastereoselektive synthese von himbacin-analoga
ATE486853T1 (de) Synthese von acylaminoalkenylenamiden als substanz-p-antagonisten
ATE554078T1 (de) Synthese von 11-beta-hydroxysteroid-dehydrogenase-1-hemmern
EP1848778A4 (de) Neusynthese von bakteriochlorinen
DK1778618T3 (da) Syntese af triethylentetraminer
EP1845849A4 (de) Exoskelett für die beine
EP1874239A4 (de) Halb angetriebenes exoskelett der unteren extremität
DK2377869T3 (da) Syntese af Bortezomib
EP1943338A4 (de) Zellfreie synthese membrangebundener polypeptide
ZA200705792B (en) Synthesis of himbacine analogs
EP2443181A4 (de) Synthese von siliciumnanostäbchen
ZA201206140B (en) An exo-selective synthesis of himbacine analogs
DE602006021628D1 (de) Verbesserte synthese und zubereitungen von duloxetinsalzen
EP1957474A4 (de) Synthese von ftsz-hemmern
ATE411269T1 (de) Hydrierung von aceton
EP1863800A4 (de) Synthese von avrainvillamid, stephacidin b und analoga davon
EP2217247A4 (de) Neue synthese von beta-nucleosiden
ATE390411T1 (de) Stereoselektive synthese von vitamin-d-analoga
DE602005025521D1 (de) Synthese von aminosäure-n-carboxyanhydriden
ATE402145T1 (de) Synthese von pyrrol-2-carbonsäurenitrilen
ATE484500T1 (de) Synthese von ccr5 rezeptor antagonisten
IL184354A0 (en) New one-step synthesis of useful disubstituted amines
DE602006006853D1 (de) Synthese von neuem Dihydrobenzoxazin
ATE479663T1 (de) Stereoselektive synthese von (s)-1-methyl-3- phenylpiperazin
EP1534783A4 (de) Synthese von cis-diolen aus arylsilanen